 Eric Hink
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbit | 7 | 2024 | 67 | 1.570 |
Why?
| | Eyelids | 7 | 2024 | 41 | 1.560 |
Why?
| | Eyelid Diseases | 5 | 2024 | 26 | 1.500 |
Why?
| | Orbital Cellulitis | 4 | 2025 | 17 | 1.200 |
Why?
| | Compartment Syndromes | 2 | 2025 | 36 | 1.050 |
Why?
| | Orbital Fractures | 4 | 2017 | 14 | 1.010 |
Why?
| | Blindness | 2 | 2025 | 51 | 0.940 |
Why?
| | Rhabdomyolysis | 1 | 2025 | 24 | 0.890 |
Why?
| | Surgical Mesh | 1 | 2024 | 50 | 0.790 |
Why?
| | Titanium | 1 | 2024 | 74 | 0.780 |
Why?
| | Tetralogy of Fallot | 1 | 2024 | 78 | 0.760 |
Why?
| | Reperfusion Injury | 1 | 2025 | 294 | 0.730 |
Why?
| | Sarcoma, Kaposi | 1 | 2022 | 83 | 0.700 |
Why?
| | Population Surveillance | 1 | 2025 | 486 | 0.690 |
Why?
| | Oculomotor Muscles | 3 | 2017 | 86 | 0.690 |
Why?
| | Eye Infections, Bacterial | 4 | 2015 | 46 | 0.660 |
Why?
| | Ophthalmologic Surgical Procedures | 7 | 2015 | 91 | 0.630 |
Why?
| | Eye Infections, Fungal | 3 | 2017 | 20 | 0.630 |
Why?
| | Orbital Diseases | 2 | 2017 | 37 | 0.620 |
Why?
| | Skull Neoplasms | 1 | 2017 | 22 | 0.510 |
Why?
| | Sphenoid Bone | 1 | 2017 | 15 | 0.510 |
Why?
| | Down Syndrome | 1 | 2024 | 526 | 0.500 |
Why?
| | Meningioma | 1 | 2017 | 88 | 0.470 |
Why?
| | Blepharophimosis | 1 | 2013 | 4 | 0.390 |
Why?
| | Candidiasis | 1 | 2013 | 64 | 0.380 |
Why?
| | Eye Injuries | 2 | 2014 | 53 | 0.370 |
Why?
| | Prostheses and Implants | 3 | 2024 | 137 | 0.360 |
Why?
| | Conjunctiva | 1 | 2011 | 52 | 0.330 |
Why?
| | Surgical Wound Infection | 1 | 2013 | 334 | 0.300 |
Why?
| | Visual Acuity | 5 | 2025 | 498 | 0.290 |
Why?
| | Golf | 1 | 2008 | 9 | 0.280 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 339 | 0.280 |
Why?
| | Child, Preschool | 11 | 2025 | 12017 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 9 | 2017 | 2791 | 0.250 |
Why?
| | Decompression, Surgical | 2 | 2025 | 117 | 0.240 |
Why?
| | Humans | 33 | 2025 | 147306 | 0.230 |
Why?
| | Inflammation | 1 | 2017 | 2921 | 0.220 |
Why?
| | Age Distribution | 1 | 2025 | 406 | 0.210 |
Why?
| | Sex Distribution | 1 | 2025 | 390 | 0.200 |
Why?
| | Alprostadil | 1 | 2024 | 29 | 0.200 |
Why?
| | Adolescent | 14 | 2025 | 22826 | 0.200 |
Why?
| | Orbital Neoplasms | 3 | 2015 | 28 | 0.200 |
Why?
| | Surgical Flaps | 3 | 2015 | 142 | 0.190 |
Why?
| | Infant | 7 | 2025 | 10195 | 0.190 |
Why?
| | Retrospective Studies | 11 | 2025 | 17561 | 0.190 |
Why?
| | Child | 12 | 2025 | 22980 | 0.190 |
Why?
| | Syndrome | 1 | 2024 | 385 | 0.190 |
Why?
| | Eye Burns | 1 | 2022 | 14 | 0.190 |
Why?
| | Dacryocystorhinostomy | 2 | 2015 | 13 | 0.180 |
Why?
| | Optic Nerve | 1 | 2022 | 67 | 0.180 |
Why?
| | Eye | 1 | 2022 | 112 | 0.170 |
Why?
| | Injections | 1 | 2022 | 200 | 0.170 |
Why?
| | Male | 17 | 2025 | 73954 | 0.160 |
Why?
| | Mucormycosis | 2 | 2017 | 18 | 0.160 |
Why?
| | Incidence | 2 | 2025 | 2954 | 0.150 |
Why?
| | Cicatrix | 2 | 2017 | 72 | 0.150 |
Why?
| | Eye Pain | 2 | 2017 | 8 | 0.140 |
Why?
| | Neoplasm Invasiveness | 2 | 2017 | 512 | 0.130 |
Why?
| | Female | 18 | 2025 | 80081 | 0.130 |
Why?
| | Mucocele | 1 | 2017 | 12 | 0.130 |
Why?
| | Mucorales | 1 | 2017 | 1 | 0.130 |
Why?
| | Paranasal Sinus Diseases | 1 | 2017 | 15 | 0.130 |
Why?
| | Graves Ophthalmopathy | 1 | 2017 | 13 | 0.130 |
Why?
| | Nose Diseases | 1 | 2017 | 17 | 0.130 |
Why?
| | Floods | 1 | 2017 | 16 | 0.130 |
Why?
| | Amnion | 1 | 2017 | 31 | 0.130 |
Why?
| | Conjunctival Diseases | 1 | 2017 | 23 | 0.130 |
Why?
| | Receptor, IGF Type 1 | 1 | 2017 | 64 | 0.130 |
Why?
| | Soft Tissue Injuries | 1 | 2017 | 35 | 0.130 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2017 | 37 | 0.120 |
Why?
| | Craniotomy | 1 | 2017 | 84 | 0.120 |
Why?
| | Corneal Diseases | 1 | 2017 | 48 | 0.120 |
Why?
| | Colorado | 2 | 2025 | 4591 | 0.120 |
Why?
| | Endoscopy | 2 | 2017 | 322 | 0.120 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1518 | 0.120 |
Why?
| | Critical Care | 1 | 2022 | 705 | 0.120 |
Why?
| | Infant, Newborn | 3 | 2025 | 6543 | 0.110 |
Why?
| | Disasters | 1 | 2017 | 104 | 0.110 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 8 | 0.110 |
Why?
| | Vision Disorders | 1 | 2017 | 179 | 0.110 |
Why?
| | Lacrimal Apparatus | 1 | 2015 | 11 | 0.110 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2015 | 11 | 0.110 |
Why?
| | Streptococcal Infections | 3 | 2015 | 179 | 0.110 |
Why?
| | Polyglycolic Acid | 1 | 2015 | 44 | 0.110 |
Why?
| | Absorbable Implants | 1 | 2015 | 38 | 0.110 |
Why?
| | Biopsy | 2 | 2017 | 1093 | 0.110 |
Why?
| | Immunologic Factors | 1 | 2017 | 261 | 0.110 |
Why?
| | Prednisone | 1 | 2015 | 230 | 0.100 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2014 | 12 | 0.100 |
Why?
| | Osteotomy | 1 | 2015 | 130 | 0.100 |
Why?
| | Facial Paralysis | 1 | 2014 | 23 | 0.100 |
Why?
| | Exophthalmos | 2 | 2017 | 18 | 0.100 |
Why?
| | Lactic Acid | 1 | 2015 | 295 | 0.100 |
Why?
| | Platinum | 1 | 2014 | 48 | 0.100 |
Why?
| | Mycobacterium chelonae | 1 | 2013 | 8 | 0.100 |
Why?
| | Silicone Elastomers | 1 | 2013 | 7 | 0.100 |
Why?
| | Jaw Fractures | 1 | 2013 | 2 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2014 | 5478 | 0.100 |
Why?
| | School Admission Criteria | 1 | 2013 | 35 | 0.100 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2015 | 195 | 0.100 |
Why?
| | Facial Bones | 1 | 2013 | 28 | 0.100 |
Why?
| | C-Reactive Protein | 1 | 2015 | 430 | 0.090 |
Why?
| | Bites and Stings | 1 | 2013 | 30 | 0.090 |
Why?
| | Skull Fractures | 1 | 2013 | 36 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 5 | 2017 | 3980 | 0.090 |
Why?
| | Gold | 1 | 2014 | 116 | 0.090 |
Why?
| | Eye Injuries, Penetrating | 1 | 2013 | 19 | 0.090 |
Why?
| | Surgery, Plastic | 1 | 2013 | 53 | 0.090 |
Why?
| | Analgesics | 1 | 2015 | 231 | 0.090 |
Why?
| | Eye Foreign Bodies | 1 | 2013 | 23 | 0.090 |
Why?
| | Adult | 10 | 2022 | 41406 | 0.090 |
Why?
| | Sinusitis | 1 | 2015 | 230 | 0.090 |
Why?
| | Suture Techniques | 1 | 2013 | 138 | 0.090 |
Why?
| | Ophthalmology | 1 | 2013 | 121 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 180 | 0.090 |
Why?
| | Adenoma | 1 | 2014 | 219 | 0.090 |
Why?
| | Dogs | 1 | 2013 | 518 | 0.090 |
Why?
| | Aged, 80 and over | 6 | 2015 | 8432 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2015 | 537 | 0.080 |
Why?
| | Middle Aged | 9 | 2017 | 36821 | 0.080 |
Why?
| | Fracture Fixation, Internal | 1 | 2013 | 214 | 0.080 |
Why?
| | Endophthalmitis | 1 | 2010 | 46 | 0.080 |
Why?
| | Retinal Neoplasms | 1 | 2010 | 47 | 0.080 |
Why?
| | Retinoblastoma | 1 | 2010 | 53 | 0.080 |
Why?
| | Intraoperative Complications | 1 | 2011 | 158 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1514 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 357 | 0.070 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2010 | 139 | 0.070 |
Why?
| | Streptococcus agalactiae | 1 | 2010 | 118 | 0.070 |
Why?
| | Education, Medical, Graduate | 1 | 2013 | 568 | 0.070 |
Why?
| | Burkitt Lymphoma | 1 | 2008 | 61 | 0.070 |
Why?
| | Decision Making | 1 | 2014 | 994 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3372 | 0.060 |
Why?
| | Aged | 7 | 2017 | 26516 | 0.060 |
Why?
| | Sweat Gland Neoplasms | 1 | 2006 | 8 | 0.060 |
Why?
| | Eyelid Neoplasms | 1 | 2006 | 11 | 0.060 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2006 | 77 | 0.050 |
Why?
| | Biomarkers | 1 | 2015 | 4354 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2017 | 11947 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2013 | 3022 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2017 | 2080 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 395 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2022 | 332 | 0.040 |
Why?
| | Anti-Bacterial Agents | 3 | 2015 | 1940 | 0.040 |
Why?
| | Young Adult | 2 | 2017 | 14437 | 0.030 |
Why?
| | Prospective Studies | 3 | 2015 | 8166 | 0.030 |
Why?
| | Diplopia | 1 | 2017 | 28 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2017 | 79 | 0.030 |
Why?
| | Ocular Motility Disorders | 1 | 2017 | 42 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2017 | 202 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 225 | 0.030 |
Why?
| | Nasolacrimal Duct | 1 | 2015 | 12 | 0.030 |
Why?
| | Pregabalin | 1 | 2015 | 12 | 0.030 |
Why?
| | Blepharoplasty | 1 | 2015 | 9 | 0.030 |
Why?
| | Bone Nails | 1 | 2015 | 64 | 0.030 |
Why?
| | Perioperative Period | 1 | 2015 | 71 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2017 | 381 | 0.020 |
Why?
| | Venous Thrombosis | 1 | 2015 | 199 | 0.020 |
Why?
| | Administration, Oral | 1 | 2015 | 874 | 0.020 |
Why?
| | Pain Measurement | 1 | 2015 | 569 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 251 | 0.020 |
Why?
| | ROC Curve | 1 | 2014 | 626 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2142 | 0.020 |
Why?
| | Foreign Bodies | 1 | 2013 | 110 | 0.020 |
Why?
| | Pain Management | 1 | 2015 | 415 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1302 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2017 | 1005 | 0.020 |
Why?
| | Microscopy, Acoustic | 1 | 2010 | 10 | 0.020 |
Why?
| | Eye Enucleation | 1 | 2010 | 16 | 0.020 |
Why?
| | Athletic Injuries | 1 | 2017 | 576 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1281 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1371 | 0.020 |
Why?
| | Etoposide | 1 | 2008 | 169 | 0.020 |
Why?
| | Maxilla | 1 | 2007 | 36 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2008 | 277 | 0.020 |
Why?
| | Methotrexate | 1 | 2008 | 235 | 0.020 |
Why?
| | Mohs Surgery | 1 | 2006 | 30 | 0.010 |
Why?
| | Doxorubicin | 1 | 2008 | 411 | 0.010 |
Why?
| | Prognosis | 1 | 2014 | 4384 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2006 | 222 | 0.010 |
Why?
| | Quality of Life | 1 | 2017 | 3246 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 6164 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 2001 | 0.010 |
Why?
| | United States | 1 | 2013 | 16313 | 0.010 |
Why?
| | Animals | 1 | 2013 | 38417 | 0.000 |
Why?
|
|
Hink's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|